Placebo News and Research

RSS

Study links gut microbiome modulation to changes in social behavior

Taking pro- and prebiotics could make people more sensitive to fairness, even at the cost of earning less money, according to a study.

15 May 2024

Semaglutide shows significant weight loss and health benefits in four-year obesity study

A study in Nature Medicine evaluated the effects of semaglutide on weight and anthropometric outcomes in adults with obesity but without diabetes, finding significant weight loss and improved health metrics over four years. The study also highlighted the safety and tolerability of semaglutide across different BMI categories.

14 May 2024

Investigational drug shows promise in increasing oxygen uptake for patients with heart condition

People with a common heart condition were able to use significantly more oxygen while exercising after taking an investigational drug in an international clinical trial, according to a study published today in the New England Journal of Medicine.

14 May 2024

Aficamten shows promise in enhancing exercise capacity in patients with hypertrophic cardiomyopathy

Even though mortality and hospitalization rates have improved, the quality of life for those living with hypertrophic cardiomyopathy (HCM) can be compromised with limiting symptoms such as exertional dyspnoea and decreased exercise capacity.

13 May 2024

Semaglutide improves heart failure symptoms and reduces loop diuretic dose

Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure with preserved ejection fraction (HFpEF) regardless of diuretic use, according to late breaking research presented today at Heart Failure 2024, a scientific congress of the European Society of Cardiology.

13 May 2024

Aerobic exercise proves most effective for combating obesity-related inflammation

New research being presented at this year's European Congress on Obesity (ECO) in Venice, Italy (12-15 May), reveals the anti-inflammatory power of moderate-to-vigorous aerobic exercise in adults living with the low-grade inflammation of obesity, shedding light on its potential to help prevent multiple metabolic diseases including type 2 diabetes and atherosclerosis (clogged arteries).

13 May 2024

Can vitamin D3 supplementation reduce COVID-19 severity?

The effectiveness of Vitamin D3 supplementation in reducing intensive care unit admissions.

10 May 2024

Keto diet enhances fungal meningitis treatment

For the roughly 150,000 AIDS patients who come down with a life-threatening infection called fungal meningitis each year, there aren't many options.

9 May 2024

Combination immunotherapy treatment enhances immune response for people with malignant gliomas

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have pinpointed a combination immunotherapy treatment that enhances the immune response for people with malignant gliomas, an aggressive type of brain tumor that is fast growing and difficult to treat.

9 May 2024

AVAnT1A study: Investigating early COVID-19 vaccination and type 1 diabetes risk in children

Type 1 diabetes is an autoimmune disease that leads to disrupted glucose metabolism. It requires lifelong insulin therapy.

8 May 2024

Study sheds new light on the links between infections with inflammation and empathy for pain

When people are ill, they feel less empathy for others than when they are healthy. This has been confirmed by a study conducted by Ruhr University Bochum and the University of Duisburg-Essen, Germany.

8 May 2024

MS Australia urges government action on neurological research funding

MS Australia has welcomed the Government's pledge to invest in health and medical research but is concerned that not enough attention or funding is being dedicated to neurological research.

8 May 2024

MedStar Washington Hospital Center enrolls first U.S. patient in gene-editing therapy trial for heart disease

The first U.S. heart patient involved in a study for a new gene-editing therapy directly infused inside the body has successfully been enrolled at MedStar Washington Hospital Center.

6 May 2024

Study sheds light on the promising role of virtual reality in treating depression

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD).

6 May 2024

Plant-based medication may be an effective therapy to help people quit vaping

Eleven million U.S. adults use e-cigarettes to vape nicotine, and about half of them say that they want to stop, but many have trouble doing so because nicotine is an addictive drug.

6 May 2024

Janssen-Cilag seeks European approval for guselkumab in ulcerative colitis and Crohn’s disease treatment

Janssen-Cilag International NV, a Johnson & Johnson company, today announced it has submitted applications to the European Medicines Agency (EMA) seeking to expand the Marketing Authorization Application for TREMFYA® (guselkumab) to include the treatment of adult patients with moderately to severely active ulcerative colitis and moderately to severely active Crohn’s disease.

6 May 2024

Varenicline dosage increase helps persistent smokers quit

For most smokers, quitting on the first attempt is likely to be unsuccessful, but a new study from The University of Texas MD Anderson Cancer Center found patients were more likely to quit if their cessation regimen was altered and doses were increased.

3 May 2024

Placebo News and Research

Study links gut microbiome modulation to changes in social behavior

Semaglutide shows significant weight loss and health benefits in four-year obesity study

Investigational drug shows promise in increasing oxygen uptake for patients with heart condition

Aficamten shows promise in enhancing exercise capacity in patients with hypertrophic cardiomyopathy

Semaglutide improves heart failure symptoms and reduces loop diuretic dose

Aerobic exercise proves most effective for combating obesity-related inflammation

Can vitamin D3 supplementation reduce COVID-19 severity?

Keto diet enhances fungal meningitis treatment

Combination immunotherapy treatment enhances immune response for people with malignant gliomas

AVAnT1A study: Investigating early COVID-19 vaccination and type 1 diabetes risk in children

Study sheds new light on the links between infections with inflammation and empathy for pain

MS Australia urges government action on neurological research funding

MedStar Washington Hospital Center enrolls first U.S. patient in gene-editing therapy trial for heart disease

Study sheds light on the promising role of virtual reality in treating depression

Plant-based medication may be an effective therapy to help people quit vaping

Janssen-Cilag seeks European approval for guselkumab in ulcerative colitis and Crohn’s disease treatment

Varenicline dosage increase helps persistent smokers quit

Aspirin shows no benefit in preventing breast cancer recurrence, study finds

Psilocybin found to be more effective than controls for treating depression symptoms

New monoclonal antibody vaccine slashes malaria risk in children

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News